Your browser doesn't support javascript.
loading
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients.
Bessis, Didier; Bursztejn, Anne-Claire; Morice-Picard, Fanny; Capri, Yline; Barbarot, Sébastien; Aubert, Hélène; Bodet, Damien; Bourrat, Emmanuelle; Chiaverini, Christine; Poujade, Laura; Willems, Marjolaine; Rouanet, Jacques; Dompmartin-Blanchère, Anne; Geneviève, David; Gerard, Marion; Ginglinger, Emmanuelle; Hadj-Rabia, Smaïl; Martin, Ludovic; Mazereeuw-Hautier, Juliette; Bibas, Nathalie; Molinari, Nicolas; Herman, Fanchon; Phan, Alice; Rod, Julien; Roger, Hugues; Sigaudy, Sabine; Ziegler, Alban; Vial, Yoann; Verloes, Alain; Cavé, Hélène; Lacombe, Didier.
Affiliation
  • Bessis D; Department of Dermatology, Saint-Eloi Hospital, University of Montpellier, Montpellier, France.
  • Bursztejn AC; French National Reference Centre for Rare Diseases of the Skin and Mucous Membranes of Genetic Origin (MAGEC), University hospital of Montpellier, Montpellier, France.
  • Morice-Picard F; INSERM U1058, Montpellier, France.
  • Capri Y; Department of Dermatology, Brabois Hospital, University of Nancy, Nancy, France.
  • Barbarot S; French National Reference Centre for Rare Diseases of the Skin and Mucous Membranes of Genetic Origin (MAGEC), University hospital of Montpellier, Montpellier, France.
  • Aubert H; Department of Paediatric Dermatology, Pellegrin University Hospital of Bordeaux, Bordeaux, France.
  • Bodet D; Department of Clinical Genetics, Robert-Debré Hospital, Paris, France.
  • Bourrat E; French National Reference Centre for Developmental Anomalies and Malformative Syndromes - Ile de France, Robert-Debré Hospital, AP-HP, Paris, France.
  • Chiaverini C; Department of Dermatology, Hotel Dieu Hospital, University of Nantes, Nantes, France.
  • Poujade L; Department of Dermatology, Hotel Dieu Hospital, University of Nantes, Nantes, France.
  • Willems M; Department of Paediatric Haematology-Immunology-Oncology, Caen Normandie Hospital and University of Caen, Caen, France.
  • Rouanet J; French National Reference Centre for Rare Diseases of the Skin and Mucous Membranes of Genetic Origin (MAGEC), University hospital of Montpellier, Montpellier, France.
  • Dompmartin-Blanchère A; Department of Paediatric Dermatology, Robert-Debré Hospital, AP-HP, Paris, France.
  • Geneviève D; French National Reference Centre for Rare Diseases of the Skin and Mucous Membranes of Genetic Origin (MAGEC), University hospital of Montpellier, Montpellier, France.
  • Gerard M; Department of Dermatology, l'Archet 2 Hospital, University of Nice, Nice, France.
  • Ginglinger E; Department of Dermatology, Saint-Eloi Hospital, University of Montpellier, Montpellier, France.
  • Hadj-Rabia S; French National Reference Centre for Rare Diseases of the Skin and Mucous Membranes of Genetic Origin (MAGEC), University hospital of Montpellier, Montpellier, France.
  • Martin L; Department of Clinical Genetics, Arnaud de Villeneuve Hospital, University of Montpellier, Montpellier, France.
  • Mazereeuw-Hautier J; French National Reference Centre for Developmental Anomalies - and Malformative Syndromes Sud Ouest Occitanie, University hospital of Montpellier, Montpellier, France.
  • Bibas N; Department of Dermatology, d'Estaing Hospital and University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.
  • Molinari N; Department of Dermatology, Caen Normandie Hospital and University of Caen, Caen, France.
  • Herman F; Department of Clinical Genetics, Arnaud de Villeneuve Hospital, University of Montpellier, Montpellier, France.
  • Phan A; French National Reference Centre for Developmental Anomalies - and Malformative Syndromes Sud Ouest Occitanie, University hospital of Montpellier, Montpellier, France.
  • Rod J; Department of Clinical Genetics, Caen Normandie Hospital and University of Caen, Caen, France.
  • Roger H; Department of Clinical Genetics, Émile Muller Hospital, Mulhouse, France.
  • Sigaudy S; French National Reference Centre for Rare Diseases of the Skin and Mucous Membranes of Genetic Origin (MAGEC), University hospital of Montpellier, Montpellier, France.
  • Ziegler A; Department of Paediatric Dermatology, Necker-Enfants Malades Hospital, AP-HP, Paris, France.
  • Vial Y; French National Reference Centre for Rare Diseases of the Skin and Mucous Membranes of Genetic Origin (MAGEC), University hospital of Montpellier, Montpellier, France.
  • Verloes A; Department of Dermatology, Angers Hospital University, Angers, France.
  • Cavé H; French National Reference Centre for Rare Diseases of the Skin and Mucous Membranes of Genetic Origin (MAGEC), University hospital of Montpellier, Montpellier, France.
  • Lacombe D; Department of Dermatology, Larrey Hospital, University of Toulouse, Toulouse, France.
Article in En | MEDLINE | ID: mdl-38595321
ABSTRACT

BACKGROUND:

Data on dermatological manifestations of Costello syndrome (CS) remain heterogeneous and lack in validated description.

OBJECTIVES:

To describe the dermatological manifestations of CS; compare them with the literature findings; assess those discriminating CS from other RASopathies, including cardiofaciocutaneous syndrome (CFCS) and the main types of Noonan syndrome (NS); and test for dermatological phenotype-genotype correlations.

METHODS:

We performed a 10-year, large, prospective, multicentric, collaborative dermatological and genetic study.

RESULTS:

Thirty-one patients were enrolled. Hair abnormalities were ubiquitous, including wavy or curly hair and excessive eyebrows, respectively in 68% and 56%. Acral excessive skin (AES), papillomas and keratotic papules (PKP), acanthosis nigricans (AN), palmoplantar hyperkeratosis (PPHK) and 'cobblestone' papillomatous papules of the upper lip (CPPUL), were noted respectively in 84%, 61%, 65%, 55% and 32%. Excessive eyebrows, PKP, AN, CCPUL and AES best differentiated CS from CFCS and NS. Multiple melanocytic naevi (>50) may constitute a new marker of attenuated CS associated with intragenic duplication in HRAS. Oral acitretin may be highly beneficial for therapeutic management of PPHK. No significant dermatological phenotype-genotype correlation was determined between patients with and without HRAS c.34G>A (p.G12S). CONCLUSIONS AND RELEVANCE This validated phenotypic characterization of a large number of patients with CS will allow future researchers to make a positive diagnosis, and to differentiate CS from CFCS and NS.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: Francia